Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensitization Potential of ATx201 in Healthy Volunteers
NCT03375957Phase 1Completed
- Sponsor
- UNION therapeutics
- Start
- Jan 2018
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of niclosamide in atopic dermatitis (AD) (3 arms), sponsored by UNION therapeutics. Primary endpoint: Dermal Response Score at 21 days. Started Jan 2018; status: completed.
02
Drugs
niclosamide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03375957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03375957.